Literature DB >> 31586222

Association of NFκB and related-cytokines with the viral load and development of antibodies against HHV-8 in people living with HIV/AIDS.

Juliana Prado Gonçales1, Thaísa Regina Rocha Lopes1, Virginia Maria Barros de Lorena2, Melayne Rocha Aciole1, José Valter Joaquim Silva Júnior3,4, Tania Regina Tozetto-Mendoza5, Paulo Henrique Braz-Silva6, Maria Rosangela Cunha Duarte Coêlho7,8.   

Abstract

Human gammaherpesvirus 8 (HHV-8) replication is influenced by a complex interaction between viral and host elements. Here, we evaluated the expression of NFκB and TNF-α in B (CD19 +) and T (CD3 +) lymphocytes, and the serum concentration of IL-1β and IL-12 cytokines in people living with HIV/AIDS (PLHA), negative for HHV-8-related diseases, and who presented antibodies to latent or lytic antigens from HHV-8. In addition, we also evaluated the correlation of HHV-8 viral load with NFκB, TNF-α, IL-1β and IL-12 levels. The expression of NFκB (p < 0.0001) or TNF-α (p < 0.0001) in B lymphocytes (CD19 +) and the IL-1β (p < 0.0266) and IL-12 (p < 0.0001) concentrations were associated with the presence of antibodies to HHV-8 lytic antigens. The CD19 + NFκB + TNF-α + and CD3 + NFκB + TNF-α + cells were also associated with the presence of antibodies to lytic infection (p < 0.0001). Among all PLHA evaluated, only individuals with the highest titers of lytic antibodies, i.e., 1:320, had detectable HHV-8 viral load. In these, HHV-8 viral load was correlated to NFκB (r = 0.6, p = 0.003) and TNF-α (r = 0.5, p = 0.01) (both in CD19 + lymphocytes) and with IL-1β (r = 0.5, p = 0.01) and IL-12 (r = 0.6, p = 0.006) levels. We believe that viral replication and/or reactivation, in addition to being associated with the development of lytic antibodies against HHV-8, may be associated with inflammatory response via NFκB. Finally, although immune response imbalance has been previously related to HHV-8-associated diseases, our results indicate that important changes in immunity, mainly in the inflammatory response, may be clearly observed in individuals with HHV-8, but who have not yet presented clinical manifestations.

Entities:  

Keywords:  Antibodies; HHV-8; IL-12; IL-1β; Inflammation; NFκB; TNF-α; Viral load

Mesh:

Substances:

Year:  2019        PMID: 31586222     DOI: 10.1007/s00430-019-00637-2

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  54 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 3.  Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors.

Authors:  Stephen T Smale
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 4.  Cell signaling pathways engaged by KSHV.

Authors:  Annika Järviluoma; Päivi M Ojala
Journal:  Biochim Biophys Acta       Date:  2006-05-19

Review 5.  NF-kappaB and the immune response.

Authors:  M S Hayden; A P West; S Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.

Authors:  Harinivas H Krishnan; Pramod P Naranatt; Marilyn S Smith; Ling Zeng; Clark Bloomer; Bala Chandran
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.

Authors:  Vasundhara Varthakavi; Rita M Smith; Hongyu Deng; Ren Sun; Paul Spearman
Journal:  Virology       Date:  2002-06-05       Impact factor: 3.616

8.  Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions.

Authors:  Negin N Blattman; Michael Lagunoff; Joseph N Blattman; Lawrence Corey
Journal:  Front Microbiol       Date:  2014-04-04       Impact factor: 5.640

Review 9.  KSHV Genome Replication and Maintenance.

Authors:  Pravinkumar Purushothaman; Prerna Dabral; Namrata Gupta; Roni Sarkar; Subhash C Verma
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

Review 10.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

View more
  1 in total

Review 1.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.